allergy banner

Videos


Open Access Agreements with Wiley



Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Free access

Articles


Depletion of Mcpt8-expressing cells reduces lung mast cells in mice with experimental asthma

Alvarado-Vazquez, P.A., Cardenas, E.I., Das, A. and Hallgren, J. Allergy. First published: 27 November 2022

Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses

Logan, K., Bahnson, H.T., Ylescupidez, A., et al. Allergy. First published: 27 November 2022

Prepregnancy body mass index and risk of childhood asthma

Rosenquist, N.A., Richards, M., Ferber, J.R., et al. Allergy. First published: 27 November 2022

Dupilumab has a profound effect on specific-IgE levels of several food allergens in atopic dermatitis patients

Spekhorst, L.S., van de Rijst, L.P., de Graaf, M., et al. Allergy. First published: 24 November 2022

Fenebrutinib and BTK inhibition: unveiling a new target for the treatment of chronic spontaneous urticaria

Carvallo, A., Sánchez-Fernández, S. and Morales-Palacios, M.P. Allergy. First published: 24 November 2022

Recent developments in the immunopathology of COVID-19

Zhang, H.-p., Sun, Y.-l., Wang, Y.-f., et al. Allergy. First published: 24 November 2022

Bet v 1-independent sensitization to major allergens in Fagales pollen: evidence at the T cell level

Polak, D., Vollmann, U., Grilo, J., et al. Allergy. First published: 24 November 2022

Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling

Bitting, K., Hedgespeth, B., Ehrhardt-Humbert, L.C., et al. Allergy. First published: 24 November 2022

GALTectomy increases the risk of allergic rhinitis: A nationwide population-based cohort study

Lin, T.-M., Hsu, H.-C., Shen, Y.-C., et al. Allergy. First published: 22 November 2022

Nutritional metabolites as biomarker for food intake to improve dietary-based randomized control trials

Venter, C. and Frei, R. Allergy. First published: 22 November 2022

Pest sensitization to cockroach, mouse, and rat: an Italian multicenter study

Liccardi, G., Maria Beatrice, B., Calzetta, L., et al. Allergy. First published: 18 November 2022

Frequent presence of major dust mite allergens in human digestive tissues of children with gastritis

Zhou, Y., Yang, S., Lin, Q., He, Q. and Cui, Y. Allergy. First published: 18 November 2022

RAB25 coordinates filaggrin-containing keratohyalin granule maturation and affects atopic dermatitis severity

Jeong, H., Lee, N., Uhm, C., et al. Allergy. First published: 16 November 2022

Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing monoclonal antibodies: a real-life experience

Franceschini, L. and Farsi, A. Allergy. First published: 16 November 2022

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes KITD816V in blood of mastocytosis and MCAS

Navarro-Navarro, P., Alvarez-Twose, I., Pérez-Pons, A., et al. Allergy. First published: 16 November 2022

Anti-kit antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria

Terhorst-Molawi, D., Hawro, T., Grekowitz, E., et al. Allergy. First published: 16 November 2022

Precision cut intestinal slices, a novel model of acute food allergic reactions

Hung, L., Celik, A., Yin, X., et al. Allergy. First published: 14 November 2022

Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: a systematic review

Broderick, C., Ziehfreund, S., van Bart, K., et al. Allergy. First published: 10 November 2022

Fracture incidence in children after developing atopic dermatitis: A Korean nationwide birth cohort study

Lee, S.W., Shin, Y.H., Shin, J.I., et al. Allergy. First published: 09 November 2022

Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study

Sousa-Pinto, B, Schünemann, HJ, Sá-Sousa, A, et al. Allergy. First published: 03 November 2022

Prenatal diet, plasma micronutrients/metabolome and inflammatory status influence the development of atopic eczema in early childhood

Ta, L.D.H., Chan, J.C.Y., Yap, G.C., et al. Allergy. First published: 02 November 2022

In children with eczema, expansion of epitope-specific IgE is associated with peanut allergy at 5 years of age

Suprun, M., Bahnson, H.T., du Toit, G., et al. Allergy. First published: 02 November 2022

Legends of allergy and immunology: Sergio Romagnani

Maggi, E., Parronchi, P. and Annunziato, F. Allergy. First published: 01 November 2022

Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation

Benito-Villalvilla, C., de la Rocha-Muñoz, A., López-Abente, J., et al. Allergy. First published: 31 October 2022

Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation – a 24-year follow up

Tedner, S.G., Klevebro, S., Bergström, A., Kull, et al. Allergy. First published: 31 October 2022

Dysregulated lipidome of sebum in patients with atopic dermatitis

Yin, H., Qiu, Z., Zhu, R., et al. Allergy. First published: 29 October 2022

Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm

Caminati, M., Feleszko, W., Michel, M., Annesi-Maesano, I., Vitte, J. Allergy. First published: 28 October 2022

Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”

Lukaszewicz, R., Mahay, G., Boyer, O. and Martinet, J. Allergy. First published: 28 October 2022

Biomarkers of asthma relapse and lung function decline in adults with spontaneous asthma remission: a population-based cohort study

Tan, D.J., Lodge, C.J., Walters, E.H., et al. Allergy. First published: 27 October 2022

Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study

Akenroye, A., Zhou, G., Jackson, J.W., et al. Allergy. First published: 26 October 2022

Strong association of mast cells with eosinophilic esophagitis-specific signat

Alvarado, D., Lu, Y., Shoda, T., Caldwell, J.M., Keler, T. and Rothenberg, M.E. Allergy. First published: 24 October 2022

Fibrostenotic Eosinophilic Esophagitis phenotype is defined by a proliferative gene signature

Menard-Katcher, C., Liu, C., Galbraith, M.D., et al. Allergy. First published: 22 October 2022

Frequency of food allergy in Europe: an updated systematic review and meta-analysis

Spolidoro, G.C.I., Tesfaye Amera, Y., Ali, M.M., et al. Allergy. First published: 22 October 2022

Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata

Renert-Yuval, Y., Pavel, A.B., Del Duca, E., et al. Allergy. First published: 22 October 2022

Emollients for prevention of atopic dermatitis; 5-year findings from the BEEP randomised trial

Bradshaw, L.E., Wyatt, L.A., Brown, S.J., et al. Allergy. First published: 19 October 2022

Prodromes predict attacks of hereditary angioedema: Results of a prospective study

Leibovich-Nassi, I., Golander, H. and Reshef, A. Allergy. First published: 19 October 2022

COP27 Climate Change Conference: Urgent action needed for Africa and the world

Atwoli, L., Erhabor, G.E., Gbakima, A.A., et al. Allergy. First published: 18 October 2022

Furan fatty acid metabolite in newborns predicts risk of asthma

Gürdeniz, G., Kim, M., Brustad, N., et al. Allergy. First published: 17 October 2022

Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases

Walsemann, T., Böttger, M., Traidl, S., et al. Allergy. First published: 14 October 2022

Patient-reported outcome measures (PROMs) in birch pollen allergic patients treated with sublingual immunotherapy reflect real life

Bahbah, F., Gentil, C., Sousa-Pinto, B., et al. Allergy. First published: 13 October 2022

Sex hormones and asthma: the role of estrogen in asthma development and severity

Radzikowska, U. and Golebski, K. Allergy. First published: 10 October 2022

Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice

Poli, A, Oudin, A, Muller, A, et al. Allergy. First published: 09 October 2022

12-HETE promotes late-phase responses in a murine model of allergic rhinitis

Nakamura, T., Tachibana, Y. and Murata, T. Allergy. First published: 08 October 2022

Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes

Valent, P, Klion, AD, Roufosse, F, et al. Allergy. First published: 07 October 2022

Stimulation of naïve B cells with a fusion protein consisting of FlaA and Bet v 1 induces regulatory B cells ex vivo

Goretzki, A., Lin, Y.-J., Meier, C., et al. Allergy. First published: 04 October 2022

Efficacy and safety of food allergy oral immunotherapy in adults

Epstein-Rigbi, N., Levy, M.B., Nachshon, L., et al. Allergy. First published: 03 October 2022

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022

Metabolic regulation by prostaglandin E2 impairs lung group 2 innate lymphoid cell responses

Robb, CT, Zhou, Y, Felton, JM, et al. Allergy. First published: 01 October 2022

Egg and milk exposure during pregnancy and food reactions in grandchildren

Mogensen, I., Flodström, C., Nopp, A., Melén, E., Bergström, A. and Kull, I. Allergy. First published: 30 September 2022

Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis

Okada, N., Yazu, H., Shimizu, E., et al. Allergy. First published: 30 September 2022

Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases

Pavel, A.B., Del Duca, E., Cheng, J., et al. Allergy. First published: 30 September 2022

A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies – an EAACI Position paper

Vazquez-Ortiz, M., Gore, C., Alviani, C., Angier, et al. Allergy. First published: 29 September 2022

Maternal heated tobacco product use during pregnancy and allergy in offspring

Zaitsu, M., Kono, K., Hosokawa, Y., et al. Allergy. First published: 29 September 2022

Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?

Yasuma, T., D’Alessandro-Gabazza, C.N., Fujimoto, H., et al. Allergy. First published: 28 September 2022

Reply to correspondence: “Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?”

Lee, H., Cho, S.I., Yang, M.-S., Cho, S.-J. and Lee, D.H. Allergy. First published: 28 September 2022

Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis

Soyka, M.B., Ryser, F.S., Brühlmann, C., et al. Allergy. First published: 26 September 2022

Citations: 1581

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 474

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Citations: 272

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Citations: 255

Risk factors for severe and critically ill COVID-19 patients: A review

Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455

Citations: 242

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844

Citations: 175

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Citations: 117

Type 2 immunity in the skin and lungs

Akdis, CA, Arkwright, PD, Brüggen, MC, et al. Allergy. 2020; 75: 1582– 1605

Citations: 97

The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma

Eguiluz-Gracia, I, Mathioudakis, AG, Bartel, S, et al. Allergy. 2020; 75: 2170– 2184

Citations: 92

Towards a more precise diagnosis of hypersensitivity to beta-lactams — an EAACI position paper

Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315

Citations: 89

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Citations: 88

Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status

Du, H, Dong, X, Zhang, J-J, et al. Allergy. 2021; 76: 510– 532

Citations: 83

Is asthma protective against COVID-19?

Carli, G., Cecchi, L., Stebbing, J., Parronchi, P. and Farsi, A. Allergy.2021; 76: 866-868

Citations: 81

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444

Citations: 81

Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?

Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

Risk factors for severe and critically ill COVID-19 patients: A review

Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455

Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives

Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

EAACI guidelines: Anaphylaxis (2021 update)

Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Advances and recent developments in asthma in 2020

Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update

Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients

Ungar, B., Hartzell, S., Lozano-Ojalvo, D., et al. Allergy. First published: 01 October 2022

Disproportionate rate of female referrals for suspected COVID-19 vaccine allergies

Chiang, V., Kan, A.K.C., Yim, J.S.H., et al. Allergy. First published: 20 September 2022

Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines

Palomares, F., Paris, J.L., Labella, M., Doña, I., Mayorga, C. and Torres, M.J. Allergy. First published: 01 August 2022

Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies

Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022

Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry

Anvari, S., Samarakoon, U., Fu, X., et al. Allergy. First published: 16 July 2022

The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma

Kim, J.G., Zhang, A., Rauseo, A.M., et al. Allergy. First published: 15 July 2022

Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity

Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022

Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection

Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022

T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19

Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022

Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses

Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022

COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab

Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022

Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern

Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022

Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures

Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022

Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants

Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022

Are health care policies for COVID-19 evidence-based?

Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022

Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro

Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022

Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?

Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022

Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization

Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

Predictors of treatment response in chronic spontaneous urticaria

Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981

Interleukin-31: The “itchy” cytokine in inflammation and therapy

Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997

Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review

Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016

Eczema herpeticum in atopic dermatitis

Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027

Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study

Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052

Direct assessment of individual skin barrier components by electrical impedance spectroscopy

Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106

Prenatal paraben exposure and atopic dermatitis-related outcomes among children

Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132

Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154

Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy

Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202

Identification of Ulocladium chartarum as an important indoor allergen source

Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206

Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis

Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214

Legends of allergy and immunology: Sergio Bonini

Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229

Medical algorithm: Peri-operative management of mastocytosis patients

Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235

Junior Members Corner



Dear Junior Members,



ISMA-RHINA Digital 2022

The International Symposium on Molecular Allergology (ISMA) and the European Rhinallergy Meeting (RHINA) was held online on 4-5 November 2022.

We had the opportunity to learn about the latest findings in molecular allergology and rhinallergy from internationally renowned experts. A wide variety of topics were presented in different sessions, from plenary and symposium to flash talks and interactive workshop sessions, all accompanied by interesting and exciting live discussions.

During the meeting, the news of the EAACI Molecular Allergology User Guide (MAUG 2.0) were presented, and a wide range of topics on molecular diagnosis, the structure of determinants, chemical modifications of allergens, as well as the latest news on the most relevant advances in airway diseases, immunomodulation and how to transfer these advances from the bench to the clinical routine have been discussed.

The meeting was a resounding success with more than 300 participants learning about new findings to be implemented in both the clinical practice and research labs!

We look forward to seeing you at the next EAACI events!




ISMA-RHINA Digital 2022



ISMA-RHINA Digital 2022

Best regards,
The Junior Member Assembly